Table 2.
Antimicrobial resistance profiles of Enterobacterales by species.
| Citrobacter spp (2) | E. coli (6) | Enterobacter spp (10) | Klebsiella spp (28) | S. ureilytica (3) | Total resistance n (%) | |
|---|---|---|---|---|---|---|
| Amikacin | 0 (0.0) | 0 (0.0) | 7 (50.0) | 7 (50.0) | 0 (0.0) | 14 (28.6) |
| Gentamicin | 2 (100.0) | 6 (100.0) | 8 (80.0) | 26 (92.9) | 0 (0.0) | 42 (85.7) |
| Aztreonam | 0 (0.0) | 6 (100.0) | 9 (90.0) | 25 (89.3) | 0 (0.0) | 40 (81.6) |
| Ampicillin Sulbactam | 2 (100.0) | 6 (100.0) | 10 (100.0) | 28 (100.0) | 3 (100.0) | 48 (100.0) |
| Piperacillin Tazobactam | 2 (100.0) | 6 (100.0) | 8 (80.0) | 23 (82.1) | 0 (0.0) | 39 (79.6) |
| Cefotaxime | 2 (100.0) | 6 (100.0) | 9 (90.0) | 27 (96.4) | 3 (100.0) | 47 (95.9) |
| Cefepime# | 2 (100.0) | 6 (100.0) | 9 (90.0) | 27 (96.4) | 0 (0.0) | 44 (89.8) |
| Ceftriaxone | 2 (100.0) | 6 (100.0) | 9 (90.0) | 27 (96.4) | 1 (33.3) | 45 (91.8) |
| Ceftazidime | 2 (100.0) | 6 (100.0) | 9 (90.0) | 27 (96.4) | 0 (0.0) | 44 (89.8) |
| Ceftazidime Avibactam | 2 (100.0) | 4 (66.7) | 8 (80.0) | 15 (53.6) | 0 (0.0) | 29 (59.2) |
| Ceftolozane Tazobactam | N/R | 6 (100.0) | 9 (90.0) | 23 (82.1) | 0 (0.0) | 38 (80.9) |
| Meropenem | 2 (100.0) | 4 (66.7) | 8 (80.0) | 18 (64.3) | 0 (0.0) | 32 (65.3) |
| Colistin* | 0 (0.0) | 0 (0.0) | 9 (90.0) | 2 (7.1) | 3 (100.0) | 14 (28.6) |
| Tigecycline | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Fosfomycin** | 0 (0.0) | 0 (0.0) | 0 (0.0) | 7 (25.0) | 0 (0.0) | 7 (14.3) |
| Trimethoprim Sulphamethoxazole | 2 (100.0) | 6 (100.0) | 9 (90.0) | 27 (96.4) | 0 (0.0) | 44 (89.8) |
| ESBL*** | 0 (0.0) | 2 (33.3) | 1 (10.0) | 12 (44.9) | 0 (0.0) | 15 (30.6) |
| mCIM | 1 (50.0) | 4 (66.7) | 8 (80.0) | 14 (50.0) | 0 (0.0) | 27 (55.1) |
*Except for colistin, all I breakpoints represented as resistant. #SDD cefepime E. coli is reported as R.
**For fosfomycin, NS represented as R.
***ESBL is ≥ 3 times decrease in MIC when cephalosporin is tested alone compared with the addition of an inhibitor.